Lunit Reaches 1 Million Mammograms in U.S. After Volpara Acquisition
Lunit has surpassed one million mammograms in the U.S., a year after acquiring Volpara Health, announced in a press release. This milestone marks a significant expansion of Lunit's presence in North America, with its AI solutions now deployed at over 200 imaging centers and hospitals across the country.
The integration of Lunit's AI technology with Volpara's breast health expertise has enabled the company to deliver AI-powered breast cancer screening to a growing number of healthcare providers, including Rezolut, SimonMed Imaging, and UC Davis Health. By June 2025, approximately 350 to 400 radiologists are expected to utilize Lunit's technology.
Lunit and Volpara have also introduced a comprehensive Ecosystem for Cancer Detection and Care, which aims to unify AI technologies for lesion detection, workflow optimization, quality control, and patient engagement. This initiative is designed to provide clinicians with actionable insights and scalable solutions across the cancer care continuum.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
LUNGevity Awards $2 Million for Lung Nodule Risk Studies
Linearis Joins Two Canadian AI Health Data Projects
RIVANNA Files 100th Patent for Ultrasound AI
Lumana Partners With Convergint on AI Video Security
Brainomix and Pulmonary Fibrosis Foundation Partner on AI Lung Imaging Research
Daily AI Brief: the AI news that matters, in your inbox.